logo
12:24 Feb 27

Eris Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1364.10
+3.00 (+0.22%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Eris Lifesciences Ltd. Financials

Eris Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1364.10
+3.00 (+0.22%)
12:24 Feb 27
Quality
image/svg+xml

57/100
High Financial Strength

Valuation
image/svg+xml

36/100
Mid Valuation

Technical

29/100
Technically Bearish

Strength

5

Weakness

7

Opportunity

2

Threats

0

12.32 %

ROE %

5.00 %

ROA %

31.17

EPS

209.57

BVPS

12.15 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
1211.86 1347.04 1685.15 2009.14 2893.64
Operating Expenses +
781.29 862.09 1148.4 1334.32 1876.44
Raw Material
276.44 259.29 348.53 379.33 749.46
Increase Decrease in Cost
-38.17 -0.78 3.82 0.72 -35.47
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
229.3 252.25 346.16 403.82 505.09
Miscellaneous Expenses
667.74 634.77 862.55 953.49 1603.6
Operating Profit
430.57 484.95 536.75 674.82 1017.2
Other Income
8.71 26.09 11.15 23.82 18.36
Depreciation
42.98 64.7 117.09 182.6 315.46
Interest
1.8 4.15 26.17 84.8 231.29
Profit before tax and exceptio..
394.5 442.2 404.64 431.24 488.81
Exceptional Items
0 0 0 0 0
PBT
394.5 442.2 404.64 431.24 488.81
Provision for Taxation
39.36 36.41 30.48 34.18 114.2
Net Profit
355.14 405.79 374.16 397.05 374.61
NET Profit after MI
355.14 406.11 382.16 391.98 351.84
EPS
26.14 29.89 28.1 28.82 25.81
Operating Profit Margin (%)
35.53 36 31.85 33.59 35.15
Net Profit Margin (%)
29.31 30.15 22.68 19.51 12.16

Eris Lifesciences Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 54.80 54.80 54.80 54.80 54.90 54.90
FII 6.80 7.20 8.40 8.40 8.40 8.00
Public 20.40 19.40 18.20 18.10 18.00 18.60
Others 18.00 18.60 18.60 18.70 18.70 18.50
Shareholder Shares Holding %
Research 360 logo
Download Our App On: